"Barriers to Affordable Weight-Loss Drugs Persist Despite Insurance Coverage"
TL;DR Summary
High costs and limited insurance coverage are causing weight-loss patients to discontinue expensive medications like Ozempic and Wegovy, prompting companies to offer post-treatment support services such as telehealth checkups, lifestyle coaching, and community support groups for a monthly fee of up to $300 in an effort to help patients maintain their weight loss.
Topics:health#healthcare#insurance-coverage#lifestyle-coaching#medication-cost#telehealth#weight-loss
- Ozempic, Wegovy Cost Drives Weight-Loss Patients to Pricey Off-Ramp Bloomberg
- Weight loss drugs Wegovy and Zepbound remain out of reach for many who need them NBC News
- Opinion | The High Cost of Weight-Loss Drugs The New York Times
- Restrictions Eased on Bariatric Surgery Due to GLP-1 Costs Medscape
- Even among the insured, weight loss drugs are rarely prescribed, study suggests Yahoo! Voices
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
45%
97 → 53 words
Want the full story? Read the original article
Read on Bloomberg